恢复期血浆治疗因 TRALI 导致的 COVID-19 合并 ARDS。
Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
机构信息
Internal Medicine, Northwell Health, Great Neck, New York, USA
Internal Medicine, Northwell Health, Great Neck, New York, USA.
出版信息
BMJ Case Rep. 2021 Jan 28;14(1):e239762. doi: 10.1136/bcr-2020-239762.
Abstract
Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We emphasise the need to be aware of the potential risk of transfusion reactions and disease worsening with convalescent plasma administration and to weigh the risk and benefits of this therapy before administration to patients and propose that further study be done regarding the potential risks of convalescent plasma.
摘要
恢复期血浆含有来自康复患者的抗体，过去曾被用作治疗传染病的有效方法，目前也被用作治疗 COVID-19 的一种潜在治疗选择。多项研究报告称这种治疗方法是安全的。我们报告了一例患者，该患者在接受 COVID-19 的恢复期血浆治疗后出现急性呼吸窘迫综合征（ARDS），并具有提示输血相关急性肺损伤的特征。我们强调需要注意使用恢复期血浆治疗可能会出现输血反应和病情恶化的潜在风险，并在向患者使用该疗法之前权衡其风险和益处，我们还建议进一步研究恢复期血浆的潜在风险。
相似文献
1
Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
BMJ Case Rep. 2021 Jan 28;14(1):e239762. doi: 10.1136/bcr-2020-239762.
2
Transfusion-related acute lung injury in a COVID-19-positive convalescent plasma recipient: a case report.
J Int Med Res. 2021 Aug;49(8):3000605211032814. doi: 10.1177/03000605211032814.
3
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors.
Intervirology. 2022;65(4):230-235. doi: 10.1159/000524016. Epub 2022 Apr 4.
4
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
5
Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
JAMA. 2023 Nov 28;330(20):1945. doi: 10.1001/jama.2023.21872.
6
ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.
J Matern Fetal Neonatal Med. 2022 Aug;35(16):3040-3043. doi: 10.1080/14767058.2020.1797669. Epub 2020 Jul 26.
7
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2.
8
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.
9
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
10
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Pediatr Blood Cancer. 2020 Nov;67(11):e28693. doi: 10.1002/pbc.28693. Epub 2020 Sep 4.
引用本文的文献
1
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology.
NPJ Vaccines. 2025 Feb 13;10(1):30. doi: 10.1038/s41541-025-01085-1.
2
COVID-19 and Pregnancy: An Updated Review about Evidence-Based Therapeutic Strategies.
J Pers Med. 2023 Jun 23;13(7):1035. doi: 10.3390/jpm13071035.
3
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection.
J Taibah Univ Med Sci. 2023 Jun;18(3):600-638. doi: 10.1016/j.jtumed.2022.11.007. Epub 2022 Dec 17.
4
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27.
5
Why Does the Precautionary Principle Suffice for Blood Regulation?
Pharmaceut Med. 2021 Sep;35(5):281-286. doi: 10.1007/s40290-021-00400-0. Epub 2021 Sep 7.
6
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.
Life (Basel). 2021 Jul 23;11(8):734. doi: 10.3390/life11080734.
7
Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study.
Clin Microbiol Infect. 2022 Feb;28(2):292-296. doi: 10.1016/j.cmi.2021.06.009. Epub 2021 Jun 14.
本文引用的文献
1
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.
CMAJ. 2020 Jul 6;192(27):E745-E755. doi: 10.1503/cmaj.200642. Epub 2020 May 22.
2
The role of passive immunization in the age of SARS-CoV-2: an update.
Eur J Med Res. 2020 May 13;25(1):16. doi: 10.1186/s40001-020-00414-5.
3
Acute respiratory failure in COVID-19: is it "typical" ARDS?
Crit Care. 2020 May 6;24(1):198. doi: 10.1186/s13054-020-02911-9.
4
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
J Med Virol. 2020 Oct;92(10):1890-1901. doi: 10.1002/jmv.25882. Epub 2020 Jun 29.
5
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
6
The convalescent sera option for containing COVID-19.
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
7
Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.
J Infect. 2017 Mar;74(3):302-309. doi: 10.1016/j.jinf.2016.11.009. Epub 2016 Nov 17.
8
Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome.
Ann Lab Med. 2016 Jul;36(4):393-5. doi: 10.3343/alm.2016.36.4.393.
9
Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.
Lancet Respir Med. 2015 Jul;3(7):554-62. doi: 10.1016/S2213-2600(15)00180-0. Epub 2015 May 31.
10
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
Zotero 插件